Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells

Journal of Immunology

Volumn 188, Issue 6, 2012, Pages 2602-2611

  Sonobe, Yoshifumi ^a   Li, Hua ^a   Jin, Shijie ^a   Kishida, Satoshi ^b   Kadomatsu, Kenji ^b   Takeuchi, Hideyuki ^a   Mizuno, Tetsuya ^a   Suzumura, Akio ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45RB ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR ALPHA; MIDKINE; PROTEIN TYROSINE PHOSPHATASE SHP 2; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; FEMALE; FLOW CYTOMETRY; IN VIVO STUDY; INFLAMMATORY CELL; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; SEQUENCE HOMOLOGY;

ADOPTIVE TRANSFER; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL SEPARATION; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY;

EID: 84863245932     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102346     Document Type: Article

References (49)

1. Matarese, G., V. De Rosa, and A. La Cava. 2008. Regulatory CD4 T cells: sensing the environment. Trends Immunol. 29: 12-17.
2. Miyara, M., K. Wing, and S. Sakaguchi. 2009. Therapeutic approaches to allergy and autoimmunity based on Foxp3+ regulatory T-cell activation and expansion. J. Allergy Clin. Immunol. 123: 749-755; quiz 756-757.
3. O'Connor, R. A., and S. M. Anderton. 2008. Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J. Neuroimmunol. 193: 1-11.
4. Tang, Q., and J. A. Bluestone. 2006. Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 212: 217-237. (Pubitemid 44116711)
5. Klunker, S., M. M. Chong, P. Y. Mantel, O. Palomares, C. Bassin, M. Ziegler, B. Rückert, F. Meiler, M. Akdis, D. R. Littman, and C. A. Akdis. 2009. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J. Exp. Med. 206: 2701-2715.
6. Tone, Y., K. Furuuchi, Y. Kojima, M. L. Tykocinski, M. I. Greene, and M. Tone. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9: 194-202.
7. Delgado, M., E. Gonzalez-Rey, and D. Ganea. 2005. The neuropeptide vaso-active intestinal peptide generates tolerogenic dendritic cells. J. Immunol. 175: 7311-7324. (Pubitemid 41713427)
8. Lan, Y. Y., Z. Wang, G. Raimondi, W. Wu, B. L. Colvin, A. de Creus, and A. W. Thomson. 2006. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J. Immunol. 177: 5868-5877. (Pubitemid 44628800)
9. Penna, G., S. Amuchastegui, N. Giarratana, K. C. Daniel, M. Vulcano, S. Sozzani, and L. Adorini. 2007. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 178: 145-153. (Pubitemid 46033595)
10. Unger, W. W., S. Laban, F. S. Kleijwegt, A. R. van der Slik, and B. O. Roep. 2009. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur. J. Immunol. 39: 3147-3159.
11. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617. (Pubitemid 36588578)
12. Fujita, S., Y. Sato, K. Sato, K. Eizumi, T. Fukaya, M. Kubo, N. Yamashita, and K. Sato. 2007. Regulatory dendritic cells protect against cutaneous chronic graft-versus- host disease mediated through CD4+CD25+Foxp3+ regulatory T cells. Blood 110: 3793-3803. (Pubitemid 350159651)
13. Sato, K., K. Eizumi, T. Fukaya, S. Fujita, Y. Sato, H. Takagi, M. Yamamoto, N. Yamashita, A. Hijikata, H. Kitamura, et al. 2009. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease. Blood 113: 4780-4789.
14. Tsutsui, J., K. Uehara, K. Kadomatsu, S. Matsubara, and T. Muramatsu. 1991. A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. Biochem. Biophys. Res. Commun. 176: 792-797.
15. Kawai, H., W. Sato, Y. Yuzawa, T. Kosugi, S. Matsuo, Y. Takei, K. Kadomatsu, and T. Muramatsu. 2004. Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage. Am. J. Pathol. 165: 1603-1612. (Pubitemid 39435159)
16. Krzystek-Korpacka, M., K. Neubauer, and M. Matusiewicz. 2010. Circulating midkine in Crohn's disease: clinical implications. Inflamm. Bowel Dis. 16: 208- 215.
17. Maruyama, K., H. Muramatsu, N. Ishiguro, and T. Muramatsu. 2004. Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 50: 1420-1429. (Pubitemid 38608063)
18. Takada, T., K. Toriyama, H. Muramatsu, X. J. Song, S. Torii, and T. Muramatsu. 1997. Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J. Biochem. 122: 453-458. (Pubitemid 27395316)
19. Wang, J., H. Takeuchi, Y. Sonobe, S. Jin, T. Mizuno, S. Miyakawa, M. Fujiwara, Y. Nakamura, T. Kato, H. Muramatsu, et al. 2008. Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc. Natl. Acad. Sci. USA 105: 3915-3920. (Pubitemid 351723499)
20. Li, H., Y. Sonobe, H. Tabata, J. Liang, S. Jin, Y. Doi, J. Kawanokuchi, H. Takeuchi, T. Mizuno, and A. Suzumura. 2011. Tumor necrosis factor-αpromotes granulocyte-macrophage colony-stimulating factor-stimulated microglia to differentiate into competent dendritic cell-like antigen-presenting cells. Clinical and Experimental Neuroimmunology 2: 1-11.
21. Oguro, A., T. Ohtsu, Y. V. Svitkin, N. Sonenberg, and Y. Nakamura. 2003. RNA aptamers to initiation factor 4A helicase hinder cap-dependent translation by blocking ATP hydrolysis. RNA 9: 394-407. (Pubitemid 36356727)
22. Zhou, Y., Y. Sonobe, T. Akahori, S. Jin, J. Kawanokuchi, M. Noda, Y. Iwakura, T. Mizuno, and A. Suzumura. 2011. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. J. Immunol. 186: 4415-4421.
23. Sonobe, Y., H. Takeuchi, K. Kataoka, H. Li, S. Jin, M. Mimuro, Y. Hashizume, Y. Sano, T. Kanda, T. Mizuno, and A. Suzumura. 2009. Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner. J. Biol. Chem. 284: 31834-31842.
24. Francisco, L. M., V. H. Salinas, K. E. Brown, V. K. Vanguri, G. J. Freeman, V. K. Kuchroo, and A. H. Sharpe. 2009. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206: 3015-3029.
25. Freeman, G. J., A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192: 1027- 1034.
26. Rabinovich, G. A., D. Gabrilovich, and E. M. Sotomayor. 2007. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25: 267-296. (Pubitemid 46697910)
27. Nefedova, Y., P. Cheng, D. Gilkes, M. Blaskovich, A. A. Beg, S. M. Sebti, and D. I. Gabrilovich. 2005. Activation of dendritic cells via inhibition of Jak2/ STAT3 signaling. J. Immunol. 175: 4338-4346. (Pubitemid 41361968)
28. Melillo, J. A., L. Song, G. Bhagat, A. B. Blazquez, C. R. Plumlee, C. Lee, C. Berin, B. Reizis, and C. Schindler. 2010. Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function. J. Immunol. 184: 2638-2645.
29. Kortylewski, M., P. Swiderski, A. Herrmann, L. Wang, C. Kowolik, M. Kujawski, H. Lee, A. Scuto, Y. Liu, C. Yang, et al. 2009. In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat. Biotechnol. 27: 925-932.
30. Hoentjen, F., R. B. Sartor, M. Ozaki, and C. Jobin. 2005. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood 105: 689- 696.
31. Ohtani, T., K. Ishihara, T. Atsumi, K. Nishida, Y. Kaneko, T. Miyata, S. Itoh, M. Narimatsu, H. Maeda, T. Fukada, et al. 2000. Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity 12: 95-105. (Pubitemid 30069218)
32. Wang, C. Z., H. W. Su, Y. C. Hsu, M. R. Shen, and M. J. Tang. 2006. A discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration. Mol. Biol. Cell 17: 2839-2852.
33. Langlois, B., G. Perrot, C. Schneider, P. Henriet, H. Emonard, L. Martiny, and S. Dedieu. 2010. LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways. PLoS ONE 5: e11584.
34. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240. (Pubitemid 40189432)
35. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
36. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748. (Pubitemid 36227625)
37. Duong, T. T., J. St Louis, J. J. Gilbert, F. D. Finkelman, and G. H. Strejan. 1992. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36: 105-115.
38. Ferber, I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156: 5-7.
39. Gran, B., G. X. Zhang, S. Yu, J. Li, X. H. Chen, E. S. Ventura, M. Kamoun, and A. Rostami. 2002. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169: 7104-7110. (Pubitemid 36899299)
40. Zhang, G. X., B. Gran, S. Yu, J. Li, I. Siglienti, X. Chen, M. Kamoun, and A. Rostami. 2003. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 170: 2153-2160. (Pubitemid 36197439)
41. Jäger, A., V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183: 7169-7177.
42. Kroenke, M. A., T. J. Carlson, A. V. Andjelkovic, and B. M. Segal. 2008. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205: 1535-1541. (Pubitemid 351962016)
43. Vermeire, K., H. Heremans, M. Vandeputte, S. Huang, A. Billiau, and P. Matthys. 1997. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J. Immunol. 158: 5507-5513. (Pubitemid 127681260)
44. Matthys, P., K. Vermeire, T. Mitera, H. Heremans, S. Huang, and A. Billiau. 1998. Anti-IL-12 antibody prevents the development and progression of collagen- induced arthritis in IFN-gamma receptor-deficient mice. Eur. J. Immunol. 28: 2143-2151. (Pubitemid 28321298)
45. Kosiewicz, M. M., C. C. Nast, A. Krishnan, J. Rivera-Nieves, C. A. Moskaluk, S. Matsumoto, K. Kozaiwa, and F. Cominelli. 2001. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J. Clin. Invest. 107: 695-702. (Pubitemid 32225355)
46. Bouchard, P. R., R. M. Hutabarat, and K. M. Thompson. 2010. Discovery and development of therapeutic aptamers. Annu. Rev. Pharmacol. Toxicol. 50: 237- 257.
47. Farman, C. A., and D. J. Kornbrust. 2003. Oligodeoxynucleotide studies in primates: antisense and immune stimulatory indications. Toxicol. Pathol. 31 (Suppl.): 119-122. (Pubitemid 36169411)
48. Henry, S. P., P. C. Giclas, J. Leeds, M. Pangburn, C. Auletta, A. A. Levin, and D. J. Kornbrust. 1997. Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action. J. Pharmacol. Exp. Ther. 281: 810-816. (Pubitemid 27203815)
49. Marquis, J. K., and J. M. Grindel. 2000. Toxicological evaluation of oligonucleotide therapeutics. Curr. Opin. Mol. Ther. 2: 258-263. (Pubitemid 30435995)